Clinical trial
Prospective Cohort Study Evaluating Identification Rate of Sentinel Node in the Management of Endometrial Cancer Utilizing a Combined Method of Cervical and Myometrial Injections
NCT01564264 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study Evaluating Identification Rate of Sentinel Node in the Management of Endometrial Cancer Utilizing a Combined Method of Cervical and Myometrial Injections
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2012
- Completion date
- December 31, 2014
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sentinel lymph node biopsy, uterine neoplasms